Re:Canadian doctors reverse severe MS using stem cells
by erkkie on Sunday June 12, 2016 @04:47AM
(#11887258)
Not just the FDA, but the EMA in Europe as well. "Non homologous use" or "substantial manipulation" makes it an ATMP (advanced-therapy medicinal product): http://www.ema.europa.eu/docs/en_GB/document_library/Scienti...
[ Parent
| on HN ]
There are no comments on this comment yet.